Abstract
Peritoneal carcinomatosis may present along with gastrointestinal or female genital tumors (including pseudomyxoma peritonei, a variable malignancy myxoid tumor, arising from the appendix). It is also the common way of presentation of primitive peritoneal tumors (like peritoneal mesothelioma). Peritoneal carcinomatosis has been considered nearly impossible to treat with surgery until a few years ago. Moreover, the results obtained with systemic chemotherapy were poor. In the’ 80s, some authors developed and improved a new combined technique to manage peritoneal carcinomatosis, consisting in cytoreduction of neoplastic lesions, peritonectomy (removal of peritoneum macroscopically affected from tumor) and hyperthermic antiblastic peritoneal perfusion (HAPP). Carcinomatosis nodes usually affects peritoneum in preferential sites as the pelvis, the ileum-caecal angle, the right diaphragm and retrohaepatic space, the lesser omentum, the left diaphragm and paracolic spaces. In fact, in these regions the peristalsis is less effective, there are the points of peritoneal fluid absorbtion and, finally, these areas are particularly anfractuous, with virtual spaces, so the circulation of fluids is slow and neoplastic cells may easily lodge. At least, cells may deposit under action of the force of gravity. For these reasons, peritonectomy is particularly indicated in these regions. The rationale of combining hyperthermia and chemotherapy has been described in previous chapters. The peritoneal cavity can be considered a “pharmacological sanctuary” for the presence of the peritoneal-plasmatic barrier, that is independent from mesothelial layer, and preserves the leakage to systemic circulation of high molecular weight drugs as cisplatinum, mitomycin C, doxorubicin, oxaliplatinum.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Averbach AM, Sugarbaker PH. Methodologic considerations in treatment using intraperitoneal chemotherapy. Cancer Treat Res 1996; 82:289–309.
Cavaliere F, Perri P, Di Filippo F et al. Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol 2000; 74(1):41–4.
De Simone M, Barone R, Vaira M et al. Semi-closed hyperthermic-antiblastic peritoneal perfusion (HAPP) in the treatment of peritoneal carcinosis. J Surg Oncol 2003; 82(2):138–40.
Elias D, Antoun S, Raynard B et al. Treatment of peritoneal carcinomatosis using complete excision and intraperitoneal chemohyperthermia. A phase I-II study defining the best technical procedures] Chirurgie 1999; 124(4):380–9.
Gilly FN, Carry PY, Sayag AC et al. Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 1994; 41(2):124–9.
Glehen O, Sugarbaker PH, Elias D et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer. A multi-institutional study for 506 patients. J Clin Oncol 2004; 22:3284
Loggie BW, Fleming RA, McQuellon RP et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 2000 Jun; 66(6):561–8.
Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221(1):29–42.
Sugarbaker PH, Ronnett BM, Archer A et al. Pseudomyxoma peritonei syndrome. Adv Surg 1996; 30:233–80.
Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999; 6(8):727–31.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
De Simone, M., Vaira, M. (2006). Cytoreduction, Peritonectomy and Hyperthermic Antiblastic Peritoneal Perfiision for the Treatment of Peritoneal Carcinomatosis. In: Hyperthermia in Cancer Treatment: A Primer. Medical Intelligence Unit. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-33441-7_15
Download citation
DOI: https://doi.org/10.1007/978-0-387-33441-7_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-33440-0
Online ISBN: 978-0-387-33441-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)